Abbott (ABT) Completes Separation of AbbVie (ABBV)
Tweet
Share
E-mailGet Alerts ABT Hot Sheet
Join SI Premium – FREE
Abbott (NYSE: ABT) completed the separation of its research-based pharmaceuticals business, which became AbbVie, a new independent biopharmaceutical company. AbbVie will begin trading independently on the New York Stock Exchange today under the symbol "ABBV" (NYSE: ABBV).
On Nov. 28, 2012, Abbott's board of directors declared a special dividend distribution of all outstanding shares of AbbVie common stock. For every 1 share of Abbott common shares held as of close of business on Dec. 12, 2012, Abbott shareholders received 1 share of AbbVie common stock on Jan. 1, 2013.
On Nov. 28, 2012, Abbott's board of directors declared a special dividend distribution of all outstanding shares of AbbVie common stock. For every 1 share of Abbott common shares held as of close of business on Dec. 12, 2012, Abbott shareholders received 1 share of AbbVie common stock on Jan. 1, 2013.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Two Harbors receives final approval for CrossCountry Mortgage merger
- Simmons Bank chief data officer Lisa Hunter to retire
- Bunker Hill Mining to acquire Silver47 in all-share merger deal
Create E-mail Alert Related Categories
Corporate News, Hot Corp. NewsRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
